Showing results (31-40 of 106) with videos related to

Sort By:
Pageof 11
Molecular Pharmacology|September 1, 1996
Interactions of oxime reactivators with diethylphosphoryl adducts of human acetylcholinesterase and its mutant derivativesH Grosfeld, D Barak, A Ordentlich, et al.
The Journal of Biological Chemistry|May 10, 1985
Bovine interferon alpha genes. Structure and expressionB Velan, S Cohen, H Grosfeld, et al.
Journal of Child Neurology|January 1, 1994
Ipsilateral constructional apraxiaD W Lewis, T Geller
Molecular & Cellular Oncology|February 7, 2018
Intratumoral bacteria may elicit chemoresistance by metabolizing anticancer agentsLeore T Geller, Ravid Straussman
The Journal of Biological Chemistry|June 27, 2000
Hierarchy of post-translational modifications involved in the circulatory longevity of glycoproteins. Demonstration of concerted contributions of glycan sialylation and subunit assembly to the pharmacokinetic behavior of bovine acetylcholinesteraseC Kronman, T Chitlaru, E Elhanany, et al.
Molecular Pharmacology|March 1, 1994
Role of tyrosine 337 in the binding of huperzine A to the active site of human acetylcholinesteraseY Ashani, J Grunwald, C Kronman, et al.
The Journal of Biological Chemistry|November 11, 1994
The "back door" hypothesis for product clearance in acetylcholinesterase challenged by site-directed mutagenesisC Kronman, A Ordentlich, D Barak, et al.
The Biochemical Journal|August 7, 1998
Bovine acetylcholinesterase: cloning, expression and characterizationI Mendelson, C Kronman, N Ariel, et al.
The Journal of Biological Chemistry|January 5, 1993
Interrelations between assembly and secretion of recombinant human acetylcholinesteraseA Kerem, C Kronman, S Bar-Nun, et al.
The Biochemical Journal|November 1, 1995
Involvement of oligomerization, N-glycosylation and sialylation in the clearance of cholinesterases from the circulationC Kronman, B Velan, D Marcus, et al.
Pageof 11